199 related articles for article (PubMed ID: 24980832)
1. Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB.
Demchenko YN; Brents LA; Li Z; Bergsagel LP; McGee LR; Kuehl MW
Oncotarget; 2014 Jun; 5(12):4554-66. PubMed ID: 24980832
[TBL] [Abstract][Full Text] [Related]
2. A critical role for the NFkB pathway in multiple myeloma.
Demchenko YN; Kuehl WM
Oncotarget; 2010 May; 1(1):59-68. PubMed ID: 20890394
[TBL] [Abstract][Full Text] [Related]
3. The kinase NIK as a therapeutic target in multiple myeloma.
Gardam S; Beyaert R
Expert Opin Ther Targets; 2011 Feb; 15(2):207-18. PubMed ID: 21204728
[TBL] [Abstract][Full Text] [Related]
4. Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.
Demchenko YN; Glebov OK; Zingone A; Keats JJ; Bergsagel PL; Kuehl WM
Blood; 2010 Apr; 115(17):3541-52. PubMed ID: 20053756
[TBL] [Abstract][Full Text] [Related]
5. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
Annunziata CM; Davis RE; Demchenko Y; Bellamy W; Gabrea A; Zhan F; Lenz G; Hanamura I; Wright G; Xiao W; Dave S; Hurt EM; Tan B; Zhao H; Stephens O; Santra M; Williams DR; Dang L; Barlogie B; Shaughnessy JD; Kuehl WM; Staudt LM
Cancer Cell; 2007 Aug; 12(2):115-30. PubMed ID: 17692804
[TBL] [Abstract][Full Text] [Related]
6. NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells.
Sasaki Y; Calado DP; Derudder E; Zhang B; Shimizu Y; Mackay F; Nishikawa S; Rajewsky K; Schmidt-Supprian M
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10883-8. PubMed ID: 18663224
[TBL] [Abstract][Full Text] [Related]
7. The Therapeutic Potential of Targeting NIK in B Cell Malignancies.
Haselager MV; Eldering E
Front Immunol; 2022; 13():930986. PubMed ID: 35911754
[TBL] [Abstract][Full Text] [Related]
8. NIK and IKKbeta interdependence in NF-kappaB signalling--flux analysis of regulation through metabolites.
Kim HB; Evans I; Smallwood R; Holcombe M; Qwarnstrom EE
Biosystems; 2010 Feb; 99(2):140-9. PubMed ID: 19909783
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100.
Qing G; Qu Z; Xiao G
J Biol Chem; 2005 Dec; 280(49):40578-82. PubMed ID: 16223731
[TBL] [Abstract][Full Text] [Related]
10. Essential role of NF-kappa B-inducing kinase in T cell activation through the TCR/CD3 pathway.
Matsumoto M; Yamada T; Yoshinaga SK; Boone T; Horan T; Fujita S; Li Y; Mitani T
J Immunol; 2002 Aug; 169(3):1151-8. PubMed ID: 12133934
[TBL] [Abstract][Full Text] [Related]
11. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.
Yang CH; Murti A; Pfeffer LM
J Biol Chem; 2005 Sep; 280(36):31530-6. PubMed ID: 16009713
[TBL] [Abstract][Full Text] [Related]
12. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis.
Hussain AR; Ahmed SO; Ahmed M; Khan OS; Al Abdulmohsen S; Platanias LC; Al-Kuraya KS; Uddin S
PLoS One; 2012; 7(6):e39945. PubMed ID: 22768179
[TBL] [Abstract][Full Text] [Related]
14. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.
Yin L; Wu L; Wesche H; Arthur CD; White JM; Goeddel DV; Schreiber RD
Science; 2001 Mar; 291(5511):2162-5. PubMed ID: 11251123
[TBL] [Abstract][Full Text] [Related]
15. A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells.
Dhawan P; Richmond A
J Biol Chem; 2002 Mar; 277(10):7920-8. PubMed ID: 11773061
[TBL] [Abstract][Full Text] [Related]
16. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase.
Ramakrishnan P; Wang W; Wallach D
Immunity; 2004 Oct; 21(4):477-89. PubMed ID: 15485626
[TBL] [Abstract][Full Text] [Related]
17. Noncanonical NF-κB signaling is limited by classical NF-κB activity.
Gray CM; Remouchamps C; McCorkell KA; Solt LA; Dejardin E; Orange JS; May MJ
Sci Signal; 2014 Feb; 7(311):ra13. PubMed ID: 24497610
[TBL] [Abstract][Full Text] [Related]
18. NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.
Odqvist L; Sánchez-Beato M; Montes-Moreno S; Martín-Sánchez E; Pajares R; Sánchez-Verde L; Ortiz-Romero PL; Rodriguez J; Rodríguez-Pinilla SM; Iniesta-Martínez F; Solera-Arroyo JC; Ramos-Asensio R; Flores T; Palanca JM; Bragado FG; Franjo PD; Piris MA
Clin Cancer Res; 2013 May; 19(9):2319-30. PubMed ID: 23536439
[TBL] [Abstract][Full Text] [Related]
19. Mangiferin induces apoptosis in multiple myeloma cell lines by suppressing the activation of nuclear factor kappa B-inducing kinase.
Takeda T; Tsubaki M; Kino T; Yamagishi M; Iida M; Itoh T; Imano M; Tanabe G; Muraoka O; Satou T; Nishida S
Chem Biol Interact; 2016 May; 251():26-33. PubMed ID: 26996543
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of NF-kappaB-inducing kinase action.
Lin X; Mu Y; Cunningham ET; Marcu KB; Geleziunas R; Greene WC
Mol Cell Biol; 1998 Oct; 18(10):5899-907. PubMed ID: 9742107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
